PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models.

Qiu Y, Wu S, Zhong Y, Fan D, Tong Q, Xiong J, Xu K, Liu G, Liu E, Li X, Huang K

Open source

DOI
10.1038/s41380-026-03740-y
Published
2026 Jul 13
Container
Molecular psychiatry
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41380-026-03740-y,
  title = {PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models.},
  author = {Qiu Y and Wu S and Zhong Y and Fan D and Tong Q and Xiong J and Xu K and Liu G and Liu E and Li X and Huang K},
  year = {2026},
  journal = {Molecular psychiatry},
  doi = {10.1038/s41380-026-03740-y},
  url = {https://doi.org/10.1038/s41380-026-03740-y}
}

RIS

TY  - JOUR
TI  - PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models.
AU  - Qiu Y
AU  - Wu S
AU  - Zhong Y
AU  - Fan D
AU  - Tong Q
AU  - Xiong J
AU  - Xu K
AU  - Liu G
AU  - Liu E
AU  - Li X
AU  - Huang K
PY  - 2026
JO  - Molecular psychiatry
DO  - 10.1038/s41380-026-03740-y
UR  - https://doi.org/10.1038/s41380-026-03740-y
ER  - 

APA

Y, Q., S, W., Y, Z., D, F., Q, T., J, X., K, X., G, L., E, L., X, L., & K, H. (2026). PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models.. Molecular psychiatry. https://doi.org/10.1038/s41380-026-03740-y

Source records